Page last updated: 2024-08-23

miocamycin and Lung Diseases, Obstructive

miocamycin has been researched along with Lung Diseases, Obstructive in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cazzola, M; Matera, MG; PaternĂ², E; Rossi, F; Santangelo, G; Scaglione, F1
Dal Negro, R; de Conti, F; Pomari, C; Turco, P1
Ardizzi, A; Barberis, S; Galietti, F; Giorgis, GE; Miravalle, C; Oliaro, A1

Other Studies

3 other study(ies) available for miocamycin and Lung Diseases, Obstructive

ArticleYear
Impact of rokitamycin, a new 16-membered macrolide, on serum theophylline.
    Journal of chemotherapy (Florence, Italy), 1991, Volume: 3, Issue:4

    Topics: Aged; Aminophylline; Anti-Bacterial Agents; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Miocamycin; Theophylline

1991
Miocamycin doesn't affect theophylline serum levels in COPD patients.
    International journal of clinical pharmacology, therapy, and toxicology, 1988, Volume: 26, Issue:1

    Topics: Adult; Humans; Leucomycins; Lung Diseases, Obstructive; Male; Miocamycin; Theophylline; Time Factors

1988
[Use of miocamycin in the acute exacerbation of chronic obstructive bronchopneumopathy. Case material contribution].
    Minerva medica, 1987, May-15, Volume: 78, Issue:9

    Topics: Aged; Cough; Female; Fever; Humans; Leucomycins; Lung Diseases, Obstructive; Male; Middle Aged; Miocamycin

1987